According to the recent study the prefilled syringe market is projected to reach an estimated $15 billion by 2030 from $8 billion in 2023 at a CAGR of 10% from 2023 to 2030. Growth in this market is primarily driven by increasing prevalence of chronic diseases and growing home-based healthcare market.
A more than 150 page
report to understand trends, opportunities and forecast in prefilled syringe
market by material (glass-based and plastic-based), product type (conventional
and safety), design (single chamber, dual chamber, and customized), application
(anaphylaxis, diabetes, rheumatoid arthritis, and others), end user
(hospitals/clinics, ambulatory surgical centers, and others), and region (North
America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts
conventional prefilled syringes will remain the largest segment, and it is also
expected to witness the highest growth over the forecast period due to
increasing prevalence of chronic devices like diabetes, cancer, and autoimmune
diseases.
Diabetes will remain the
largest application segment over the forecast due to rise in adoption of
injectable devices, surges in the advantages of prefilled syringes, and an
increase in prevalence of chronic diseases.
Download sample by clicking on
prefilled syringe market.
APAC will remain the
fastest growing region over the forecast period due to improvements in
healthcare infrastructure, a rise in number of hospitals equipped with advanced
instruments, and development of the R&D sector.
Becton, Dickinson, and
Company, Gerresheimer AG, B. Braun Melsungen, Schott AG, Baxter International,
Nipro Corporation, and Shandong Weigao Group are the major suppliers in the prefilled
syringe market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get
access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment